Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double‐blind, placebo‐controlled, cross‐over study

AIMS: The purpose of this study was to investigate pharmacodynamic effects of drugs targeting cortical excitability using transcranial magnetic stimulation (TMS) combined with electromyography (EMG) and electroencephalography (EEG) in healthy subjects, to further develop TMS outcomes as biomarkers f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruijs, Titia Q., Heuberger, Jules A. A. C., de Goede, Annika A., Ziagkos, Dimitrios, Otto, Marije E., Doll, Robert J., van Putten, Michel J. A. M., Groeneveld, Geert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303426/
https://www.ncbi.nlm.nih.gov/pubmed/35028950
http://dx.doi.org/10.1111/bcp.15232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303426/
https://www.ncbi.nlm.nih.gov/pubmed/35028950
http://dx.doi.org/10.1111/bcp.15232

Ejemplares similares